Skip to main page content

• HOME
• Current
• Archive
• Feedback
• Subscribe
• Help

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in BJP Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by HAUG, T. T. Articles by WOLD, J. E. Search for Related Content PubMed PubMed Citation Articles by HAUG, T. T. Articles by WOLD, J. E.

The British Journal of Psychiatry (2003) 182: 312-318
© 2003 The Royal College of Psychiatrists

Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial

TONE TANGEN HAUG, MD

Haukeland University Hospital, Bergen

SVEIN BLOMHOFF, MD

National Hospital, Oslo, Norway

KERSTIN HELLSTRØM, DrMedSci

Ulleråker University Hospital, Uppsala, Sweden

INGAR HOLME, PhD

Ullevål University Hospital, Norway

MATS HUMBLE, MD

Huddinge University Hospital, Sweden

HANS PETTER MADSBU, MD

Elverum Medical Center, Elverum

JAN EGIL WOLD, MD

Innherred Hospital, Levanger, Norway

Correspondence: Tone Tangen Haug, Haukeland University Hospital, 0021 Bergen, Norway

Declaration of interest Funding was provided by Pfizer, Inc.

Background Maintenance of treatment effect is important for the choice of treatment for social phobia.

Aims To examine the effect of exposure therapy and sertraline 28 weeks after cessation of medical treatment.

Method In this study 375 patients with social phobia were randomised to treatment with sertraline or placebo for 24 weeks, with or without the addition of exposure therapy. Fifty-two weeks after inclusion, 328 patients were evaluated by the same psychometric tests as at baseline and the end of treatment (24 weeks).

Results The exposure therapy group and the placebo group had a further improvement in scores on social phobia during follow-up: mean change in the Clinical Global Impression — Social Phobia overall severity score was 0.45 (95% CI 0.16-0.65, P < 0.01) for the exposure group, and 0.25 (95% CI 0.00-0.48, P < 0.05) for the placebo group. At week 52 the sertraline plus exposure group and the sertraline-alone group had a significant deterioration on the 36-item Short Form Health Survey compared with exposure alone.

Conclusions Exposure therapy alone yielded a further improvement during follow-up, whereas exposure therapy combined with sertraline and sertraline alone showed a tendency towards deterioration after the completion of treatment.

Related articles in BJP:

Highlights of this issue

ELIZABETH WALSH
BJP 2003 182: 279-a15. [Full Text]  

This article has been cited by other articles:

				C. Gale and O. Davidson Tired and anxious BMJ, October 1, 2008; 337(oct01_2): a1241 - a1241. [Full Text]

				M. W. Otto, J. A. J. Smits, and H. E. Reese Combined Psychotherapy and Pharmacotherapy for Mood and Anxiety Disorders in Adults: Review and Analysis Focus, April 1, 2006; 4(2): 204. [Abstract] [Full Text] [PDF]

				D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol, November 1, 2005; 19(6): 567 - 596. [Abstract] [PDF]

				B. Bandelow and T. T. Haug Sertraline and exposure therapy in social phobia * Author's reply The British Journal of Psychiatry, March 1, 2004; 184(3): 271 - 272. [Full Text] [PDF]

				J. R Walker The benefits of exposure therapy alone may last longer than sertraline alone or sertraline plus exposure therapy in social phobia Evid. Based Ment. Health, August 1, 2003; 6(3): 90 - 90. [Full Text] [PDF]